TRPV4 and pulmonary arterial hypertension: TRPV4-mediated extracellular Ca2+ entry has been implicated also in neovascular diseases, such as PAH (Suresh et al., 2018) and cancer (see Section Remodeling of Endothelial TRP Channels Promote Aberrant Tumor Vascularization).